Skip to Content
Merck
  • A matrix form of fibronectin mediates enhanced binding of Streptococcus pyogenes to host tissue.

A matrix form of fibronectin mediates enhanced binding of Streptococcus pyogenes to host tissue.

The Journal of biological chemistry (1997-10-27)
N Okada, M Watarai, V Ozeri, E Hanski, M Caparon, C Sasakawa
ABSTRACT

The pathogenic Gram-positive bacterium Streptococcus pyogenes (group A streptococcus) binds to fibronectin via protein F. In this study, we have investigated the binding properties of protein F to various multimeric tissue forms of fibronectin that appear on cell surfaces and in the extracellular matrix. We show that binding of S. pyogenes through protein F is more efficient to an in vitro-derived polymerized form of fibronectin (superfibronectin) than to soluble fibronectin immobilized in a solid phase. In addition, Chinese hamster ovary cells overexpressing the alpha5beta1 integrin produced an increased amount of a fibronectin matrix and consequently bound a higher number of S. pyogenes cells. Inhibition and direct binding assays using purified proteins demonstrated that binding to a fibronectin matrix involved both domains of protein F (UR and RD2) that have previously been implicated in interactions with fibronectin. Using intact S. pyogenes bacteria in which various domains of protein F were expressed as hybrids with the surface-exposed region of an unrelated protein, we revealed that, in contrast to the predominantly UR-mediated binding to soluble fibronectin, the maximal binding to the fibronectin matrix required RD2 in addition to UR. Since in some infections S. pyogenes may initially encounter a matrix form of fibronectin, these results suggest that UR and RD2 may be important for the initiation of streptococcal infectious processes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Superfibronectin from human plasma, solution, BioReagent, suitable for cell culture
Pricing and availability is not currently available.